Dr. Luckhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Dr. Tracy Luckhardt is a pulmonary and critical care medicine physician based in Birmingham, AL. She completed her internal medicine residency and chief residency at the University of Iowa Hospitals and Clinics, followed by a fellowship in pulmonary disease and critical care medicine at the University of Michigan, where she also earned an MS in biostatistics and clinical trial design. Dr. Luckhardt is experienced in interstitial lung disease and has published research on related topics, including idiopathic pulmonary fibrosis. She is also involved in clinical trials investigating new therapies in pulmonary fibrosis and scleroderma lung disease.
Education & Training
- University of Michigan Medical SchoolMS., Biostatistics and Clinical Trial Design, 2007 - 2009
- University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
- University of Iowa Hospitals and ClinicsChief Residency, Internal Medicine, 2003 - 2004
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2003
- LSU School of Medicine in ShreveportClass of 2000
Certifications & Licensure
- AL State Medical License 2009 - 2025
- NC State Medical License 2017 - 2021
- SC State Medical License 2017 - 2021
- MI State Medical License 2004 - 2010
- IA State Medical License 2000 - 2004
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsInhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial.Steven D Nathan, Natasa Rajicic, Rosemarie Dudenhofer, Rahat Hussain, Rahul Argula
Annals of the American Thoracic Society. 2024-12-01 - 4 citationsLung function trajectories in patients with idiopathic pulmonary fibrosis.Megan L Neely, Anne S Hellkamp, Shaun Bender, Jamie L Todd, Timothy Liesching
Respiratory Research. 2023-08-24 - 11 citationsIntegrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.Peifeng Ruan, Jamie L Todd, Hongyu Zhao, Yi Liu, Richard Vinisko
Respiratory Research. 2023-05-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: